Global Peptide Synthesis CMO Competitive Landscape Professional Research Report 2026
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Peptide Synthesis CMO market size will reach 4,710 Million USD in 2026 and is projected to reach 10,648 Million USD by 2033, with a CAGR of 12.36% (2026-2033). Notably, the China Peptide Synthesis CMO market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide Synthesis CMO is a specialized custom synthesis service aimed at research institutions, biopharmaceutical companies, and biotech enterprises, providing high-quality and diverse peptide production solutions. The service covers the entire process from amino acid sequence design, chemical synthesis, purification, and analysis to scale-up production, ensuring peptides of high purity, stability, and reproducibility. Peptide Synthesis CMO can customize peptides of varying lengths, modifications, and labels according to client requirements, while offering quality control and analytical reports to meet the needs of drug development, vaccine research, diagnostic reagents, and functional studies. By utilizing professional peptide synthesis outsourcing, companies and researchers can save development time, reduce experimental costs, and rapidly obtain reliable peptide samples, accelerating drug discovery and scientific research, and providing efficient technical support for the life sciences and pharmaceutical sectors.
The major global suppliers of Peptide Synthesis CMO include Bachem, PolyPeptide, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, AmbioPharm, SN Biopharm, CBL, Piramal Pharma, CordenPharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide Synthesis CMO. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide Synthesis CMO market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Synthesis CMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Synthesis CMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide Synthesis CMO Include:
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Peptide Synthesis CMO Product Segment Include:
APIs and Intermediates
FDF
Peptide Synthesis CMO Product Application Include:
Commercial
Academic Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide Synthesis CMO Industry PESTEL Analysis
Chapter 3: Global Peptide Synthesis CMO Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide Synthesis CMO Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide Synthesis CMO Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide Synthesis CMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Peptide Synthesis CMO market size will reach 4,710 Million USD in 2026 and is projected to reach 10,648 Million USD by 2033, with a CAGR of 12.36% (2026-2033). Notably, the China Peptide Synthesis CMO market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Peptide Synthesis CMO is a specialized custom synthesis service aimed at research institutions, biopharmaceutical companies, and biotech enterprises, providing high-quality and diverse peptide production solutions. The service covers the entire process from amino acid sequence design, chemical synthesis, purification, and analysis to scale-up production, ensuring peptides of high purity, stability, and reproducibility. Peptide Synthesis CMO can customize peptides of varying lengths, modifications, and labels according to client requirements, while offering quality control and analytical reports to meet the needs of drug development, vaccine research, diagnostic reagents, and functional studies. By utilizing professional peptide synthesis outsourcing, companies and researchers can save development time, reduce experimental costs, and rapidly obtain reliable peptide samples, accelerating drug discovery and scientific research, and providing efficient technical support for the life sciences and pharmaceutical sectors.
The major global suppliers of Peptide Synthesis CMO include Bachem, PolyPeptide, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, AmbioPharm, SN Biopharm, CBL, Piramal Pharma, CordenPharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide Synthesis CMO. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide Synthesis CMO market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Synthesis CMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Synthesis CMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide Synthesis CMO Include:
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific
Peptide Synthesis CMO Product Segment Include:
APIs and Intermediates
FDF
Peptide Synthesis CMO Product Application Include:
Commercial
Academic Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide Synthesis CMO Industry PESTEL Analysis
Chapter 3: Global Peptide Synthesis CMO Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide Synthesis CMO Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide Synthesis CMO Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide Synthesis CMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide Synthesis CMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Peptide Synthesis CMO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptide Synthesis CMO Product by Type
- 1.2.1 APIs and Intermediates
- 1.2.2 FDF
- 1.3 Peptide Synthesis CMO Product by Application
- 1.3.1 Commercial
- 1.3.2 Academic Research
- 1.3.3 Other
- 1.4 Global Peptide Synthesis CMO Market Size Analysis (2021-2033)
- 1.5 Peptide Synthesis CMO Market Development Status and Trends
- 1.5.1 Peptide Synthesis CMO Industry Development Status Analysis
- 1.5.2 Peptide Synthesis CMO Industry Development Trends Analysis
- 2 Peptide Synthesis CMO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptide Synthesis CMO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptide Synthesis CMO Market Analysis by Regions
- 4.1 Peptide Synthesis CMO Overall Market: 2025 VS 2026 VS 2033
- 4.2 Global Peptide Synthesis CMO Revenue and Forecast Analysis (2021-2033)
- 4.2.1 Global Peptide Synthesis CMO Revenue and Market Share by Region (2021-2026)
- 4.2.2 Global Peptide Synthesis CMO Revenue and Market Share Forecast by Region (2027-2033)
- 5 Global Peptide Synthesis CMO Market Size by Type and Application
- 5.1 Global Peptide Synthesis CMO Market Size by Type (2021-2033)
- 5.2 Global Peptide Synthesis CMO Market Size by Application (2021-2033)
- 6 North America
- 6.1 North America Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 6.2 North America Key Suppliers Analysis
- 6.3 North America Peptide Synthesis CMO Market Size by Type
- 6.4 North America Peptide Synthesis CMO Market Size by Application
- 6.5 North America Peptide Synthesis CMO Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 7.2 Europe Key Suppliers Analysis
- 7.3 Europe Peptide Synthesis CMO Market Size by Type
- 7.4 Europe Peptide Synthesis CMO Market Size by Application
- 7.5 Europe Peptide Synthesis CMO Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 8.2 China Key Suppliers Analysis
- 8.3 China Peptide Synthesis CMO Market Size by Type
- 8.4 China Peptide Synthesis CMO Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 9.2 APAC (excl. China) Key Suppliers Analysis
- 9.3 APAC (excl. China) Peptide Synthesis CMO Market Size by Type
- 9.4 APAC (excl. China) Peptide Synthesis CMO Market Size by Application
- 9.5 APAC (excl. China) Peptide Synthesis CMO Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 10.2 Latin America Key Suppliers Analysis
- 10.3 Latin America Peptide Synthesis CMO Market Size by Type
- 10.4 Latin America Peptide Synthesis CMO Market Size by Application
- 10.5 Latin America Peptide Synthesis CMO Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Synthesis CMO Market Size and Growth Rate Analysis (2021-2033)
- 11.2 Middle East & Africa Key Suppliers Analysis
- 11.3 Middle East & Africa Peptide Synthesis CMO Market Size by Type
- 11.4 Middle East & Africa Peptide Synthesis CMO Market Size by Application
- 11.5 Middle East & Africa Peptide Synthesis CMO Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Suppliers
- 12.1 Global Peptide Synthesis CMO Market Revenue by Key Suppliers (2021-2033)
- 12.2 Peptide Synthesis CMO Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Peptide Synthesis CMO Competitive Landscape Analysis
- 12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bachem
- 13.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bachem Peptide Synthesis CMO Product Portfolio
- 13.1.3 Bachem Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.2 PolyPeptide
- 13.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 PolyPeptide Peptide Synthesis CMO Product Portfolio
- 13.2.3 PolyPeptide Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.3 USV Peptides
- 13.3.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 USV Peptides Peptide Synthesis CMO Product Portfolio
- 13.3.3 USV Peptides Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.4 Thermofischer
- 13.4.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Thermofischer Peptide Synthesis CMO Product Portfolio
- 13.4.3 Thermofischer Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.5 Bio Basic
- 13.5.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Bio Basic Peptide Synthesis CMO Product Portfolio
- 13.5.3 Bio Basic Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.6 JPT
- 13.6.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 JPT Peptide Synthesis CMO Product Portfolio
- 13.6.3 JPT Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.7 Genscript
- 13.7.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Genscript Peptide Synthesis CMO Product Portfolio
- 13.7.3 Genscript Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.8 Xinbang Pharma
- 13.8.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Xinbang Pharma Peptide Synthesis CMO Product Portfolio
- 13.8.3 Xinbang Pharma Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.9 ScinoPharm
- 13.9.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 ScinoPharm Peptide Synthesis CMO Product Portfolio
- 13.9.3 ScinoPharm Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.10 AmbioPharm
- 13.10.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 AmbioPharm Peptide Synthesis CMO Product Portfolio
- 13.10.3 AmbioPharm Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.11 SN Biopharm
- 13.11.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 SN Biopharm Peptide Synthesis CMO Product Portfolio
- 13.11.3 SN Biopharm Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.12 CBL
- 13.12.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 CBL Peptide Synthesis CMO Product Portfolio
- 13.12.3 CBL Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.13 Piramal Pharma
- 13.13.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Piramal Pharma Peptide Synthesis CMO Product Portfolio
- 13.13.3 Piramal Pharma Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.14 CordenPharma
- 13.14.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 CordenPharma Peptide Synthesis CMO Product Portfolio
- 13.14.3 CordenPharma Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 13.15 CPC Scientific
- 13.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 CPC Scientific Peptide Synthesis CMO Product Portfolio
- 13.15.3 CPC Scientific Peptide Synthesis CMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)
- 14 Industry Chain Analysis
- 14.1 Peptide Synthesis CMO Industry Chain Analysis
- 14.2 Peptide Synthesis CMO Typical Downstream Customers
- 14.3 Peptide Synthesis CMO Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
